Thalassemia is a preventable genetic blood disorder in which the patient's body cannot make sufficient red blood cells (RBC) on its own and require ... May 07
Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA... Feb 17
Orca Bio, today announced the first clinical data from its first-generation investigational therapy,... Dec 07
Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-... Dec 04
FDA approves expanded indication for Merck’s KEYTRUDA (pembrolizumab) in adult patients with relapsed or refractory classical hodgkin lymphoma (cHL) ... Oct 16
... Oct 15
Researchers show that stem cell therapy has a better and long-lasting effect on Neurological disorders.... Mar 19
-Advertisements-